Does pDE5 inhibition alleviate functional muscle ischemia in boys with Duchenne muscular dystrophy?
These data provide in-human proof of concept for PDE5 inhibition as a putative new therapeutic strategy for DMD.
Lower serum sKl levels are independently associated with severe AAC. Serum sKl might have a diagnostic value for the severe AAC in MHD patients.